HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’

An HIV Vaccine Might Be Closer Than We Think… In Part Thanks to COVID-19

Dr. Larry Corey, principal investigator at the HIV Vaccine Trials Network, reflects on the progress made in HIV vaccine trials over the years and how mRNA technology is helping acc

Vaccination induces HIV broadly neutralizing antibody precursors in humans

Open the article to view the coverage from Science

HIV vaccine candidate shows early promise

The vaccine, called eOD-GT8 60mer, had a “favorable safety profile” and induced broadly neutralizing antibodies in 97%, or all but one, of the 36 recipients, according to the researcher…

HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'

An experimental HIV vaccine has been found to induce broadly neutralizing antibody precursors among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.

HIV vaccine candidate induces immune response in early clinical trial

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study.

HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune…